In Vivo Flow Cytometry of Circulating Tumor-Associated Exosomes

Circulating tumor cells (CTCs) demonstrated the potential as prognostic markers of metastatic development. However, the incurable metastasis can already be developed at the time of initial diagnosis with the existing CTC assays. Alternatively, tumor-associated particles (CTPs) including exosomes can...

Full description

Saved in:
Bibliographic Details
Main Authors: Jacqueline Nolan, Mustafa Sarimollaoglu, Dmitry A. Nedosekin, Azemat Jamshidi-Parsian, Ekaterina I. Galanzha, Rajshekhar A. Kore, Robert J. Griffin, Vladimir P. Zharov
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2016/1628057
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850220161744764928
author Jacqueline Nolan
Mustafa Sarimollaoglu
Dmitry A. Nedosekin
Azemat Jamshidi-Parsian
Ekaterina I. Galanzha
Rajshekhar A. Kore
Robert J. Griffin
Vladimir P. Zharov
author_facet Jacqueline Nolan
Mustafa Sarimollaoglu
Dmitry A. Nedosekin
Azemat Jamshidi-Parsian
Ekaterina I. Galanzha
Rajshekhar A. Kore
Robert J. Griffin
Vladimir P. Zharov
author_sort Jacqueline Nolan
collection DOAJ
description Circulating tumor cells (CTCs) demonstrated the potential as prognostic markers of metastatic development. However, the incurable metastasis can already be developed at the time of initial diagnosis with the existing CTC assays. Alternatively, tumor-associated particles (CTPs) including exosomes can be a more valuable prognostic marker because they can be released from the primary tumor long before CTCs and in larger amount. However, little progress has been made in high sensitivity detection of CTPs, especially in vivo. We show here that in vivo integrated photoacoustic (PA) and fluorescence flow cytometry (PAFFC) platform can provide the detection of melanoma and breast-cancer-associated single CTPs with endogenously expressed melanin and genetically engineered proteins or exogenous dyes as PA and fluorescent contrast agents. The two-beam, time-of-light PAFFC can measure the sizes of CTCs and CTPs and identify bulk and rolling CTCs and CTC clusters, with no influence on blood flow instability. This technique revealed a higher concentration of CTPs than CTCs at an early cancer stage. Because a single tumor cell can release many CTPs and in vivo PAFFC can examine the whole blood volume, PAFFC diagnostic platform has the potential to dramatically improve (up to 105-fold) the sensitivity of cancer diagnosis.
format Article
id doaj-art-77e6e46bb32943bcbdd688739436ce68
institution OA Journals
issn 2210-7177
2210-7185
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-77e6e46bb32943bcbdd688739436ce682025-08-20T02:07:09ZengWileyAnalytical Cellular Pathology2210-71772210-71852016-01-01201610.1155/2016/16280571628057In Vivo Flow Cytometry of Circulating Tumor-Associated ExosomesJacqueline Nolan0Mustafa Sarimollaoglu1Dmitry A. Nedosekin2Azemat Jamshidi-Parsian3Ekaterina I. Galanzha4Rajshekhar A. Kore5Robert J. Griffin6Vladimir P. Zharov7Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USADepartment of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USADepartment of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USAArkansas Nanomedicine Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USADepartment of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USAArkansas Nanomedicine Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USAArkansas Nanomedicine Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USADepartment of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USACirculating tumor cells (CTCs) demonstrated the potential as prognostic markers of metastatic development. However, the incurable metastasis can already be developed at the time of initial diagnosis with the existing CTC assays. Alternatively, tumor-associated particles (CTPs) including exosomes can be a more valuable prognostic marker because they can be released from the primary tumor long before CTCs and in larger amount. However, little progress has been made in high sensitivity detection of CTPs, especially in vivo. We show here that in vivo integrated photoacoustic (PA) and fluorescence flow cytometry (PAFFC) platform can provide the detection of melanoma and breast-cancer-associated single CTPs with endogenously expressed melanin and genetically engineered proteins or exogenous dyes as PA and fluorescent contrast agents. The two-beam, time-of-light PAFFC can measure the sizes of CTCs and CTPs and identify bulk and rolling CTCs and CTC clusters, with no influence on blood flow instability. This technique revealed a higher concentration of CTPs than CTCs at an early cancer stage. Because a single tumor cell can release many CTPs and in vivo PAFFC can examine the whole blood volume, PAFFC diagnostic platform has the potential to dramatically improve (up to 105-fold) the sensitivity of cancer diagnosis.http://dx.doi.org/10.1155/2016/1628057
spellingShingle Jacqueline Nolan
Mustafa Sarimollaoglu
Dmitry A. Nedosekin
Azemat Jamshidi-Parsian
Ekaterina I. Galanzha
Rajshekhar A. Kore
Robert J. Griffin
Vladimir P. Zharov
In Vivo Flow Cytometry of Circulating Tumor-Associated Exosomes
Analytical Cellular Pathology
title In Vivo Flow Cytometry of Circulating Tumor-Associated Exosomes
title_full In Vivo Flow Cytometry of Circulating Tumor-Associated Exosomes
title_fullStr In Vivo Flow Cytometry of Circulating Tumor-Associated Exosomes
title_full_unstemmed In Vivo Flow Cytometry of Circulating Tumor-Associated Exosomes
title_short In Vivo Flow Cytometry of Circulating Tumor-Associated Exosomes
title_sort in vivo flow cytometry of circulating tumor associated exosomes
url http://dx.doi.org/10.1155/2016/1628057
work_keys_str_mv AT jacquelinenolan invivoflowcytometryofcirculatingtumorassociatedexosomes
AT mustafasarimollaoglu invivoflowcytometryofcirculatingtumorassociatedexosomes
AT dmitryanedosekin invivoflowcytometryofcirculatingtumorassociatedexosomes
AT azematjamshidiparsian invivoflowcytometryofcirculatingtumorassociatedexosomes
AT ekaterinaigalanzha invivoflowcytometryofcirculatingtumorassociatedexosomes
AT rajshekharakore invivoflowcytometryofcirculatingtumorassociatedexosomes
AT robertjgriffin invivoflowcytometryofcirculatingtumorassociatedexosomes
AT vladimirpzharov invivoflowcytometryofcirculatingtumorassociatedexosomes